Tags : Qarziba

BeiGene Collaborates with EUSA Pharma to Develop and Commercialize Sylvant

Tuba Khan January 13, 2020

Shots: EUSA to receive up front, up to $160M milestones and royalties on sales of products in the licensed territories. BeiGene to get an exclusive right to develop & commercialize […]readmore

Tags : Qarziba

BeiGene Collaborates with EUSA Pharma to Develop and Commercialize Sylvant

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Qarziba

BeiGene Collaborates with EUSA Pharma to Develop and Commercialize Sylvant

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company